Literature DB >> 7837392

Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.

K F Hoskins1, J E Stopfer, K A Calzone, S D Merajver, T R Rebbeck, J E Garber, B L Weber.   

Abstract

More women in all risk categories are seeking information regarding their individual breast cancer risk, and there is a need for their primary care clinicians to be able to assess familial risk factors for breast cancer, provide individualized risk information, and offer surveillance recommendations. Estimates of the number of women with a family history of breast cancer range from approximately 5% to 20%, depending on the population surveyed. Many of these women will not have a family history that suggests the presence of a highly penetrant breast cancer susceptibility gene. However, a small subset of such women will come from families with a striking incidence of breast and other cancers often associated with inherited mutations. The development and refinement of risk prediction models provide an epidemiologic basis for counseling women with a family history that does not appear related to a dominant susceptibility gene. contrast, the recent isolation of BRCA1, the localization of BRCA2, and the acknowledgement that additional breast cancer susceptibility genes must exist provide a molecular basis for counseling some high-risk women. We present a guide for primary care clinicians that may be helpful in defining families as moderate or high risk, in determining individual risk in women with a family history of breast cancer based on this distinction, and for counseling women in a setting where the data necessary to design surveillance and prevention strategies are lacking. We include criteria for selecting women who may be candidates for detection of inherited mutations in breast cancer susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7837392

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  60 in total

1.  General practitioners' views on genetic screening for common diseases.

Authors:  M A Suchard; P Yudkin; J S Sinsheimer; G H Fowler
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

Review 2.  Why should primary care physicians know about breast cancer genetics?

Authors:  L E Pinsky; J B Culver; J Hull; E Levy-Lahad; M Daly; W Burke
Journal:  West J Med       Date:  2001-09

Review 3.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

4.  Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.

Authors:  F Durocher; P Tonin; D Shattuck-Eidens; M Skolnick; S A Narod; J Simard
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

5.  Addressing women's breast cancer risk and perceptions of control in medical settings.

Authors:  R Royak-Schaler; B Cheuvront; K R Wilson; C M Williams
Journal:  J Clin Psychol Med Settings       Date:  1996-09

6.  Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?

Authors:  O M Serova; S Mazoyer; N Puget; V Dubois; P Tonin; Y Y Shugart; D Goldgar; S A Narod; H T Lynch; G M Lenoir
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

7.  Clinical breast examination.

Authors:  W H Goodson
Journal:  West J Med       Date:  1996-04

Review 8.  The new genetics. Implications for clinical services in Britain and the United States.

Authors:  A L Kinmonth; J Reinhard; M Bobrow; S Pauker
Journal:  BMJ       Date:  1998-03-07

Review 9.  Molecular genetic testing for adult-onset disorders: the evolving laboratory, physician, patient interface.

Authors:  R T Acton
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

10.  BRCA1 Testing: Genetic Counseling Protocol Development and Counseling Issues.

Authors:  B J Baty; V L Venne; J McDonald; R T Croyle; C Halls; J E Nash; J R Botkin
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.